Cited 11 times in
The optimum bolus dose of remifentanil to facilitate laryngeal mask airway insertion with a single standard dose of propofol at induction in children.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김지영 | - |
dc.date.accessioned | 2015-05-19T17:06:32Z | - |
dc.date.available | 2015-05-19T17:06:32Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0003-2409 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/107520 | - |
dc.description.abstract | The purpose of this study was to determine the optimal bolus dose of remifentanil required for the successful insertion of the laryngeal mask airway during propofol induction in children without a neuromuscular blocking agent. Twenty-six paediatric patients, aged 3-10 years, requiring anaesthesia for short ambulatory surgery were recruited. A predetermined bolus dose of remifentanil was injected over 30 s, followed by propofol 2.5 mg.kg(-1) over 10 s. The bolus dose of remifentanil was determined by a modified Dixon's up-and-down method, starting from 0.5 microg.kg(-1) (0.1 microg.kg(-1) as a step size). Laryngeal mask insertion was attempted 90 s after the end of remifentanil injection and the response of patients was classified as either 'movement' or 'no movement'. The bolus dose of remifentanil at which there was a 50% probability of successful laryngeal mask insertion (ED(50)) during induction with 2.5 mg.kg(-1) propofol was 0.56 (0.07) microg.kg(-1) in children without a neuromuscular blocking agent. From probit analysis, the ED(50) and ED(95) of remifentanil were 0.52 microg.kg(-1) (95% confidence limits, 0.42-0.62 microg.kg(-1)) and 0.71 microg.kg(-1) (95% confidence limits, 0.61-1.40 microg.kg(-1)), respectively. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 954~958 | - |
dc.relation.isPartOf | ANAESTHESIA | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Ambulatory Surgical Procedures | - |
dc.subject.MESH | Anesthetics, Combined/administration & dosage* | - |
dc.subject.MESH | Anesthetics, Intravenous/administration & dosage* | - |
dc.subject.MESH | Blood Pressure/drug effects | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | Child, Preschool | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Heart Rate/drug effects | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Laryngeal Masks* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Piperidines/administration & dosage* | - |
dc.subject.MESH | Propofol/administration & dosage* | - |
dc.subject.MESH | Remifentanil | - |
dc.title | The optimum bolus dose of remifentanil to facilitate laryngeal mask airway insertion with a single standard dose of propofol at induction in children. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anesthesiology (마취통증의학) | - |
dc.contributor.googleauthor | H. J. Kwak | - |
dc.contributor.googleauthor | J. Y. Kim | - |
dc.contributor.googleauthor | Y. B. Kim | - |
dc.contributor.googleauthor | Y. J. Chae | - |
dc.contributor.googleauthor | J. Y. Kim | - |
dc.identifier.doi | 10.1111/j.1365-2044.2008.05544.x | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00977 | - |
dc.relation.journalcode | J00128 | - |
dc.identifier.eissn | 1365-2044 | - |
dc.identifier.pmid | 18557970 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.2008.05544.x/abstract | - |
dc.subject.keyword | Ambulatory Surgical Procedures | - |
dc.subject.keyword | Anesthetics, Combined/administration & dosage* | - |
dc.subject.keyword | Anesthetics, Intravenous/administration & dosage* | - |
dc.subject.keyword | Blood Pressure/drug effects | - |
dc.subject.keyword | Child | - |
dc.subject.keyword | Child, Preschool | - |
dc.subject.keyword | Dose-Response Relationship, Drug | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Heart Rate/drug effects | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Laryngeal Masks* | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Piperidines/administration & dosage* | - |
dc.subject.keyword | Propofol/administration & dosage* | - |
dc.subject.keyword | Remifentanil | - |
dc.contributor.alternativeName | Kim, Ji Young | - |
dc.contributor.affiliatedAuthor | Kim, Ji Young | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 63 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 954 | - |
dc.citation.endPage | 958 | - |
dc.identifier.bibliographicCitation | ANAESTHESIA, Vol.63(9) : 954-958, 2008 | - |
dc.identifier.rimsid | 57262 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.